Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers

Title
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
Authors
Keywords
Ovarian cancer, Everolimus, Aromatase inhibitors, PDX models
Journal
GYNECOLOGIC ONCOLOGY
Volume 146, Issue 1, Pages 64-68
Publisher
Elsevier BV
Online
2017-04-29
DOI
10.1016/j.ygyno.2017.04.020

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started